23 Sep 2020
// BUSINESSWIRE
16 Jan 2018
// Eric Sagonowsky FIERCE PHARMA
https://www.fiercepharma.com/pharma/tesaro-s-chemo-nausea-med-varubi-can-cause-anaphylaxis-company-warns
25 Oct 2017
// GLOBENEWSWIRE
https://globenewswire.com/news-release/2017/10/25/1153687/0/en/TESARO-Announces-U-S-FDA-Approval-of-VARUBI-IV-for-Delayed-Nausea-and-Vomiting-Associated-With-Cancer-Chemotherapy.html
31 May 2017
// EMA
https://www.pharmacompass.com/pdf/news/tesaros-varuby-rolapitant-receives-approval-in-europe-1496315673.pdf
31 May 2017
// EMA
https://www.pharmacompass.com/pdf/news/tesaro-uk-varuby-rolapitant-receives-approval-in-europe-1496838419.pdf
27 Feb 2017
// Selina McKee PHARMATIMES
http://www.pharmatimes.com/news/six_new_medicines_endorsed_for_eu_approval_1187675